VIR
#1977
Vir Biotechnology, Inc. - Common Stock
11.3 0 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.42%
Variación mensual
+5.31%
Variación en los últimos 6 meses
+20.86%
Cambio anual
+88.96%
Cierres anteriores
11.7 0
Open
11.6 3
Mínimo
11.2 1
Máximo
11.8 2
Financials
- Market Capitalization 1.91 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.91
Relación precio/flujo de caja
12.18
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1953 |  FTRE Fortrea Holdings Inc. - Common Stock | 21.00 USD | +0.77% | -4.55% | +21.95% | +121.99% | 2.00 B USD | ||
| 1961 |  MLYS Mineralys Therapeutics, Inc. - Common Stock | 22.23 USD | -4.88% | -5.56% | -21.00% | -44.93% | 1.97 B USD | ||
| 1978 |  XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.46 USD | -0.19% | +2.25% | +37.81% | +31.24% | 1.91 B USD | ||
| 1990 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 38.28 USD | +3.94% | -11.47% | -9.63% | +101.47% | 1.87 B USD |